SuperworthKorro Bio market cap KRRO
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $176.4M
- Highest close in our data
- $1.9B
- Feb 2021
Korro Bio is worth $176.4M at the close on Oct 23, 2026, at $11.98 a share.
That is down 51% over the last year and down 18% over five years.
Its highest close in our data was $1.9B in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $176.4M | $75.8M | $210M | +131% |
| 2025 | $76.5M | $53.7M | $434M | −80% |
| 2024 | $374.7M | $30.4M | $744.3M | +959% |
| 2023 | $35.4M | $8.5M | $167.5M | −74% |
| 2022 | $135.8M | $38.1M | $189.3M | −24% |
| 2021 | $177.5M | $174M | $1.9B | −85% |
| 2020 | $1.2B | $464.8M | $1.2B | +111% |
| 2019 | $564.6M | $475.3M | $568.9M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Korro Bio's size, closest first, today.
| Company | Market cap |
|---|---|
| KRROKorro Bio | $176.4M |
| NATRNatures Sunshine Products | $213.8M |
| LFVNLifevantage | $73.4M |
| ARVNArvinas | $477.3M |
| SPROSpero Therapeutics | $64.6M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Korro Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.